Bluebird Bio Inc. sell Morgan Stanley
Start price
03.04.23
/
50%
€3.03
Target price
03.04.24
€2.76
Performance (%)
-64.27%
End price
04.04.24
€1.08
Summary
This prediction ended on 04.04.24 with a price of €1.08. The SELL prediction by Morgan_Stanley for Bluebird Bio Inc. performed very well with a performance of -64.27%. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Bluebird Bio Inc. | -7.900% | -7.900% | -78.663% |
| iShares Core DAX® | -1.370% | -3.231% | 11.661% |
| iShares Nasdaq 100 | 0.172% | -3.339% | 36.491% |
| iShares Nikkei 225® | -0.801% | -7.859% | 18.597% |
| iShares S&P 500 | -0.369% | -2.979% | 26.341% |
Comments by Morgan_Stanley for this prediction
In the thread Bluebird Bio Inc. diskutieren
bluebird bio, Inc. (NASDAQ: BLUE) had its price target lowered by analysts at Morgan Stanley from $4.00 to $3.00. They now have an "underweight" rating on the stock.
Ratings data for BLUE provided by MarketBeat
In the thread Trading Bluebird Bio Inc.
Die von Morgan_Stanley gewählte maximale Laufzeit wurde überschritten